| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |